Sort   by:  
 Page size 
UnknownThe clinical trial activation process: a case study of an Italian public hospital.
Not available
S-EPMC10998293 | biostudies-literature
UnknownTumor Immune Microenvironment and Genetic Alterations in Mesothelioma.
Not available
S-EPMC8261295 | biostudies-literature
UnknownBaseline clinical characteristics and prognostic factors in hospitalized COVID-19 patients aged ≤ 65 years: A retrospective observational study.
Not available
S-EPMC7990225 | biostudies-literature
UnknownIdentification of novel COX-2 / CYP19A1 axis involved in the mesothelioma pathogenesis opens new therapeutic opportunities.
Not available
S-EPMC8369782 | biostudies-literature
UnknownEpigenetic investigation into circulating microRNA 197-3p in sera from patients affected by malignant pleural mesothelioma and workers ex-exposed to asbestos.
Not available
S-EPMC10119131 | biostudies-literature
UnknownShort-long term near infrared spectroscopy patterns after different milk regimens olfactory stimuli in late preterms.
Not available
S-EPMC11994012 | biostudies-literature
UnknownPleural mesothelioma patients and ex-exposed asbestos workers are immunologically poor responders to oncogenic Merkel cell polyomavirus
Not available
S-EPMC12337077 | biostudies-literature
UnknownDiagnostics of BAP1-Tumor Predisposition Syndrome by a Multitesting Approach: A Ten-Year-Long Experience.
Not available
S-EPMC9317020 | biostudies-literature
UnknownLong-term benefit of lurbinectedin as palliative chemotherapy in progressive malignant pleural mesothelioma (MPM): final efficacy and translational data of the SAKK 17/16 study.
Not available
S-EPMC9271468 | biostudies-literature
UnknownFatality rate and predictors of mortality in an Italian cohort of hospitalized COVID-19 patients.
Not available
S-EPMC7692524 | biostudies-literature
Sort   by:  
 Page size